Financials Lunit Inc.

Equities

A328130

KR7328130000

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. 23:00:00 22/05/2024 BST 5-day change 1st Jan Change
57,500 KRW +1.05% Intraday chart for Lunit Inc. +3.98% -29.79%

Valuation

Fiscal Period: December 2022 2023 2024 2025
Capitalization 1 364,383 2,332,210 1,657,761 -
Enterprise Value (EV) 2 364.4 2,130 1,488 1,478
P/E ratio -7.95 x - - -
Yield - - - -
Capitalization / Revenue - 93 x 31 x 17.2 x
EV / Revenue - 84.9 x 27.8 x 15.3 x
EV / EBITDA - -55.4 x -113 x 62.7 x
EV / FCF - - - -
FCF Yield - - - -
Price to Book - 10 x 7.72 x 7.3 x
Nbr of stocks (in thousands) 24,455 28,476 28,831 -
Reference price 3 14,900 81,900 57,500 57,500
Announcement Date 21/03/23 15/02/24 - -
1KRW in Million2KRW in Billions3KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025
Net sales 1 - 25.08 53.55 96.38
EBITDA 1 - -38.44 -13.15 23.55
EBIT 1 - -42.18 -15.22 22.9
Operating Margin - -168.19% -28.42% 23.77%
Earnings before Tax (EBT) - - - -
Net income 1 -39.12 -36.75 -15.73 12.2
Net margin - -146.52% -29.38% 12.66%
EPS -1,874 - - -
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share 2 - - - -
Announcement Date 21/03/23 15/02/24 - -
1KRW in Billions2KRW
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1 2023 Q2
Net sales 1 - 5.445
EBITDA - -
EBIT 1 - -10.04
Operating Margin - -184.46%
Earnings before Tax (EBT) 1 - -9.996
Net income 1 -2.086 -9.996
Net margin - -183.56%
EPS -85.00 -
Dividend per Share - -
Announcement Date 10/05/23 11/08/23
1KRW in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025
Net Debt 1 - - - -
Net Cash position 1 - 202 170 180
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - - -
ROE (net income / shareholders' equity) - -24.2% -7.1% 5.55%
ROA (Net income/ Total Assets) - - - -
Assets 1 - - - -
Book Value Per Share 2 - 8,191 7,448 7,873
Cash Flow per Share 2 - -1,419 -476.0 448.0
Capex - - - -
Capex / Sales - - - -
Announcement Date 21/03/23 15/02/24 - -
1KRW in Billions2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
57,500 KRW
Average target price
100,000 KRW
Spread / Average Target
+73.91%
Consensus

Annual profits - Rate of surprise